| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfe1ad3b27a506e4dcede75d5db6cb1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_003fa00b2da60d6d52ceba7217f03560
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35263a5e3bfd9f155ac5c61e08a7db97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-342 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate |
2008-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f82f0ae0e42e0874d5ff95c2ef4f60b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871b489719e782d5648297b9a8641fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faa9d739afb091f1c07d871134b94b9c |
| publicationDate |
2010-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010189659-A1 |
| titleOfInvention |
Diagnostic substance and method for the diagnosis of prostate diseases |
| abstract |
A diagnostic substance for use in a method for diagnosing prostate diseases contains multiple different coupling molecules that respectively bind to signal molecules (target molecules) of a molecular surface structure of a pathological tissue that is associated with a prostate disease. A first of the coupling molecules specifically binds to signal molecules of cancer tissue, and a second of the coupling molecules specifically binds to signal molecules formed in inflamed tissue. First and second markers are respectively associated with the first and second coupling molecules, the first and second markers being detectable, and differentiated from each other, with a detection device. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014267773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9939130-B2 |
| priorityDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |